Stay updated on Nivolumab + Celecoxib in Cold Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Celecoxib in Cold Tumors Clinical Trial page.

Latest updates to the Nivolumab + Celecoxib in Cold Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3, indicating a small update to the page's revision history.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page metadata/version marker was updated from **Revision: v3.5.2** to **Revision: v3.5.3** without any visible change to the study record information.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page revision shows v3.5.0 added and v3.4.3 removed.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded a new site revision entry v3.4.3 and removed the previous entry v3.4.2 from the revision log.SummaryDifference0.1%

- Check102 days agoChange DetectedAdded Revision: v3.4.2 banner; removed Revision: v3.4.1 notice and a government funding lapse notice. These are maintenance updates and do not affect the trial details, eligibility criteria, or results on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Nivolumab + Celecoxib in Cold Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Celecoxib in Cold Tumors Clinical Trial page.